←Back to Expert Scholars
Translational Medicine / 转化医学HER2 NSCLC, Oncogene Driven Lung Cancer
Julien Mazieres
MD, PhD
🏢Toulouse University Hospital🌐France
Professor of Pulmonology, Head of Thoracic Oncology
60
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Julien Mazieres leads European efforts in oncogene driven NSCLC including HER2 mutant disease. He established the EUHER2 registry that characterized HER2 mutant lung cancer outcomes across Europe. He participates in major international ADC and HER2 targeted therapy trials.
Share:
🧪Research Fields 研究领域
HER2 mutant NSCLC
oncogene driven lung cancer
European trials
registries
targeted therapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Julien Mazieres 的研究动态
Follow Julien Mazieres's research updates
留下邮箱，当我们发布与 Julien Mazieres（Toulouse University Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment